Venture Leaders Biotech 2024: 10 innovative startups selected for the Boston roadshow

The Swiss National Startup Team welcomes new members: 10 startups have been selected for the Venture Leaders Biotech 2024. The entrepreneurs will meet international investors and industry leaders during their roadshow and access industry-specific expertise to grow their ventures.

Selected from over 70 applications by a jury of investors and biotech experts, the ten startups will join the roadshow in Boston, one of the world's most important life science hubs. From May 13 to May 17, 2024, the roadshow will connect the participants with international investors and industry leaders, accelerating their ventures' expansion in the US.

The Venture Leaders Biotech will introduce themselves and their startups at a kick-off event at the Swiss Biotech Day in Basel on April 22, 2024.

The startups will follow in the footsteps of high-flying former team members such as Covagen (acquired by Johnson & Johnson), Versantis (acquired by Genfit), SimplicityBio (acquired by Precision for Medicine), AMAL Therapeutics (acquired by Boehringer Ingelheim), NBE-Therapeutics (acquired by Boehringer Ingelheim), Alentis (USD 105 million funding round in 2023), and Interax Biotech (Seed round with US investors met during the roadshow). With the biotech industry comprising 39% of Swiss exports, the Venture Leaders Biotech program contributes to the enduring strength and vitality of the sector.

“Preparing for this roadshow for the 18th year is a tribute to the quality of innovation and startups that have been part of this journey,” shared Jordi Montserrat, Co-Founder and CEO of Venturelab. “I can’t wait to join this new edition and support this new team in their international expansion.”

"Thanks to our preparation during the roadshow, we engaged with VCs and pharma contacts, giving us invaluable exposure. Our team's mix of youth and experience taught us to thrive together," commented Mamta Chabria, Co-founder and CEO of Tandem Therapeutics and Venture Leaders Biotech 2023 participant.

Venture Leaders Biotech is organized by Venturelab in partnership with Swissnex in Boston and supported by Debiopharm, EPFL, ETH Zurich, Hansjörg Wyss, Kellerhals Carrard, Novartis, Swiss Biotech Association, and VISCHER.

Follow the entrepreneurs and the Venture Leaders Biotech roadshow on social media using the hashtag #VLeadersBiotech or on https://www.venturelab.swiss/venture-leaders-biotech.



About Venture Leaders
The Venture Leaders – Swiss National Startup Team members – have a clear goal: they want to take the first step towards international expansion, envisioning themselves as global players. Venturelab has 18 years of experience bringing Switzerland’s best entrepreneurs to the heart of technology hotspots: Silicon Valley, Boston, China, London, Barcelona, and Munich. Companies founded by the 500 Venture Leaders alumni have created more than 9,800 jobs and raised more than CHF 7.6 billion in capital. For more information, visit https://www.venturelab.swiss/ventureleaders. Discover all the alumni here.